ZymoGenetics' rheumatoid arthritis drug test goes poorly - Bizjournals.com

ZymoGenetics' rheumatoid arthritis drug test goes poorly Bizjournals.com ... Merck Serono International SA, and Merck hasn't made a further decision on whether it will target atacicept at rheumatoid arthritis. ... ZymoGenetics' arthritis drug hits roadblockReuters ZymoGenetics (Nasdaq: ZGEN) Said Studies Results Did Not Meet ...StreetInsider.com (subscription) Zymo Drug Fails Arthritis TrialsSeattle Post Intelligencer The Associated Press all 57 news articles »

BRIEF-Galapagos starts 2nd phase I trial for rheumatoid arthritis drug - Forbes

BRIEF-Galapagos starts 2nd phase I trial for rheumatoid arthritis drug Forbes Initiates second phase I clinical trial for GLPG0259, a candidate drug for rheumatoid arthritis (RA). * Says the new trial is based on the positive outcome ... Galapagos Initiates Second Phase I Clinical Trial For GLPG0259Pharmaceutical Business Review all 23 news articles »

Array shares fall after rheumatoid arthritis drug fails trial - Forbes

Array shares fall after rheumatoid arthritis drug fails trial Forbes Sept 4 (Reuters) - Shares of Array BioPharma Inc fell 28 percent on Friday, a day after the company said its compound to treat rheumatoid arthritis (RA) ... Shares of Array BioPharma Fall After Drug FailureFOXBusiness Array Plunges After Arthritis Pill Fails TrialBloomberg Array BioPharma Announces Top-Line Results from Rheumatoid ...Reuters Bizjournals.com -FierceBiotech -Forbes all 43 news articles »

Impact Arthritis event sheds light on pain, treatment - LaSalle News Tribune

Impact Arthritis event sheds light on pain, treatment LaSalle News Tribune Keynote speaker Dr. Richard Olson of Rockford Orthopedic Associates began the day with a session on rheumatoid arthritis. ...